@jdsindy13 @MeloDotty @stclairashley @CaptainBlackEy1 Here you go... https://t.co/tHMY73DdkL
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/coaGlDVqPd
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%) showed clinical improvement in oxygen-support class 17/30 (57%) receiving mechanical ventilation who were extubated 25/53 (47%) disc
@AmericanDiva4 @svflybynight @StarCatChris @JNJNews @NBCNightlyNews And here is the paper... https://t.co/tHMY73DdkL
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
@AliAbdelWahabMD
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Remdesivir results!
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/xLqQOFWG5e
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in very sick patients on mechanical ventilation with 18% fatality (only, expect > 50%) and overall 68% improvement https://t.co/oP8e
First non-controlled data for #remdesivir in #COVID19, 68% of patients showing clinical improvement, 18% mortality for invasive ventilation compares favorably to 50-80% benchmark for this population $Gild https://t.co/sDxQbw84pm
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
Compassionate Use of Remdesivir for Patients with Severe #COVID19 | NEJM ➡️ improvement in oxygen-support status was observed in 68% of patients ➡️ this is a small cohort study, we have to wait for the RCT to see efficacy & comparison with placebo. h
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…